Skip to main content
Caplight Logo









Oloker Therapeutics

Oloker Therapeutics

Private
BariHealthcare & Life Scienceshttps://www.oloker.com/

Last Round

Seed

Apr 2, 2021

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Oloker Therapeutics operates in Healthcare & Life Sciences and is based in Bari. Its latest recorded funding round was a Seed round in April 2021.

Oloker Therapeutics is a biotechnology company that develops cellular therapies for the treatment of cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Oloker Therapeutics Comparables

Compare Oloker Therapeutics with similar companies based on industry and business-model similarity.

Oloker Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Secretome Therapeutics
69%
CytoHub Inc.
45%
Pluri
42%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Oloker Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 2, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Oloker Therapeutics Investors

Notable investors and investment history

Oloker Therapeutics investors
InvestorRounds
Siryo SpASeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 1208% MoM, reaching 2.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Oloker Therapeutics Filings

Explore SEC and related filing metadata, where available.

Oloker Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Oloker Therapeutics's valuation, stock price, and market status.

Is Oloker Therapeutics a public or private company?

Oloker Therapeutics is a private company.

What is the current stock price of Oloker Therapeutics?

Oloker Therapeutics is a private company, so its shares have no public market price. Caplight tracks Oloker Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Oloker Therapeutics worth (valuation)?

Valuation information for Oloker Therapeutics is not publicly available.

Can I buy Oloker Therapeutics stock?

Oloker Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Oloker Therapeutics's last funding round?

Oloker Therapeutics's most recent funding round was Seed on April 2, 2021.

Who are the main investors in Oloker Therapeutics?

Key investors in Oloker Therapeutics include Siryo SpA.

Will Oloker Therapeutics IPO soon?

No public IPO plans have been announced for Oloker Therapeutics.

How can I track Oloker Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in Oloker Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersBari
Employee Range5
Year Founded2021
Last FundingApr 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?